BIOVIA: Unify Your Scientific Innovation from Molecule to Manufacturing

BIOVIA unifies your R&D on the AI-powered 3DEXPERIENCE® platform. Trusted by 2,000+ top pharmaceutical, CPG and materials science leaders.

What is BIOVIA by Dassault Systèmes?

BIOVIA, the scientific innovation brand of Dassault Systèmes, accelerates innovative products to market through the power of Generative AI. It offers comprehensive software to connect biological, chemical and material innovations, creating a seamless digital thread from R&D to quality and manufacturing.

Millions of scientists innovate faster and make more confident, data-driven decisions with BIOVIA.

BIOVIA solutions use the 3DEXPERIENCE platform, establishing a unified, collaborative environment for scientific data. Powered by Scientific AI, BIOVIA transforms your data to enable predictive modeling, generative design and intelligent automation.

BIOVIA's Tangible Results

Faster Time to Mkt > Circle Image > Dassault Systèmes®

Up to 50% Time-to-Market

Accelerate new product launches by connecting R&D, manufacturing, and quality on a single platform.

R&D Productivity > Circle Image > Dassault Systèmes®

Up to 40% Higher R&D Productivity

Eliminate manual data transfer and repetitive tasks, allowing scientists to focus on innovation.

less Compliance Delays > Circle Image > Dassault Systèmes®

60-80% Less Compliance Delays

Streamline regulatory workflows and ensure data integrity with a validation-ready, GxP-compliant system.

Less Data Inconsistency > Circle Image > Dassault Systèmes®

90% Better Data Consistency

Establish a single source of scientific truth, eliminating the risks and rework associated with fragmented data silos.

Explore the BIOVIA Solutions Portfolio

The BIOVIA portfolio provides end-to-end solutions across key scientific disciplines, enabling you to manage the entire innovation lifecycle. 

BIOVIA Scientific AI > Image> Dassault Systèmes®

BIOVIA Scientific AI

Leverage scientifically-aware Generative AI across the entire BIOVIA portfolio. Scientific AI gives scientists purpose-built tools to accelerate molecular discovery, optimize experiments, and enhance quality assurance across the R&D and manufacturing lifecycle on the 3DEXPERIENCE platform.

BIOVIA for Biosciences & Pharmaceuticals

Accelerate drug discovery and development. BIOVIA Discovery Studio Simulation and BIOVIA Generative Therapeutics Design allow scientists to combine Scientific AI with advanced molecular modeling and simulation for the design and optimization of small molecule and biological therapeutics. BIOVIA Discoverant provides manufacturing process experts with insights for monitoring, fault detection, and optimization, ensuring efficient manufacturing.

BIOVIA for Biosciences & Pharmaceuticals > Image > Dassault Systèmes®
BIOVIA for Materials Science & Engineering > Image > Dassault Systèmes®

BIOVIA for Materials Science & Engineering

Foster innovation through silico design. BIOVIA Materials Studio and COSMO-RS enable scientists to predict and understand material properties at the atomic level, accelerating the development of next-generation materials such as batteries, sustainable polymers, advanced catalysts, and more.

BIOVIA for Laboratory Informatics

Optimize lab productivity and compliance with a unified digital environment. BIOVIA ONE Lab integrates an ELN (Electronic Lab Notebook), LIMS, and LES (for procedure execution), along with inventory management and dedicated equipment management. Choose the components that address your needs today, and multiply the value as you add more of the integrations together.

BIOVIA for Laboratory Informatics > Image > Dassault Systèmes®
BIOVIA for Quality & Regulatory Management > Image > Dassault Systèmes®

BIOVIA for Quality & Regulatory Management

Ensure end-to-end digital quality and compliance. BIOVIA solutions streamline quality processes, automate documentation, and ensure data integrity from the lab to regulatory submission.

How BIOVIA Compares to Other Scientific Software

Capability Typical Scientific Software (Point Solutions & Open Source) The BIOVIA Unified Platform Approach
Platform Architecture Fragmented systems that are specialized for individual tasks (e.g., modeling, ELN, or data analysis). A single, integrated platform that unifies all scientific disciplines and functions.
Data Management Data is stored in separate, disconnected systems, leading to inconsistency and manual data transfer. A unified data model creates one "single source of truth" for all scientific information.  
Lifecycle Coverage Focus on specific stages like discovery, lab management, or manufacturing, creating gaps in the digital thread. A seamless digital thread from early discovery to manufacturing and quality control ("Molecule to Manufacturing").  
Collaboration Collaboration is often limited to specific teams or departments, making cross-functional work difficult. Connects all stakeholders—R&D, labs, quality, manufacturing—in a single, real-time, collaborative environment.
AI & Analytics AI models are trained on siloed, incomplete datasets, limiting their predictive power and context. Scientific AI is trained on a complete, contextualized dataset, delivering accurate and relevant insights.  
Compliance & Validation Compliance and validation are often managed manually or are specific to one application, requiring significant effort. A "validation-ready" platform with built-in GxP support, electronic signatures, and audit trails to streamline compliance.  
Support & Deployment Support may be community-based or vendor-specific for one tool. Deployment is often limited to one model (cloud or on-premise). Enterprise-level global support across the entire platform with flexible deployment options (Cloud, On-Premise, or Hybrid).  

How Leaders Succeed with BIOVIA

💡​​​​​​​ Customer Story: R&D Customer Saves $30 Million Annually with BIOVIA

  • Challenge: The R&D of a company was facing significant inefficiencies, including manual data mining and a 30-40% repetition of experimental work due to a lack of knowledge sharing.
  • Solution: The company deployed BIOVIA Pipeline Pilot to automate data delivery and established a BIOVIA-based digital backbone for its labs, creating a "paperless science" environment for 4,000 scientists.
  • Results: The BIOVIA platform enabled an "In-silico first" strategy, fostered collaboration and increased lab productivity, resulting in estimated savings of $30 million per year.


💡​​​​​​​ Customer Story: Global CPG Leader Transforms Virtual Product Development with BIOVIA

  • Challenge: A multinational CPG company was hindered by poor R&D connectivity, lengthy compliance cycles, and the constant need to "reinvent the wheel" for new products.
  • Solution: The company adopted BIOVIA ONE Lab and the 3DEXPERIENCE platform to drive a "model-first" innovation strategy, capturing structured data to build predictive models for everything from recipe performance to packaging strength.
  • Results: The BIOVIA solution created a user-friendly environment for virtual product development, democratized simulation for all R&D teams, and dramatically improved data-driven innovation, allowing them to predict consumer opinions and reduce plastic in packaging. 


💡​​​​​​​ Customer Story: Large Biopharma Accelerates Drug Design with BIOVIA AI

  • Challenge: A leading biopharmaceutical company was interested in incorporating AI/machine learning into small molecule drug discovery to accelerate timelines and reduce costs, but found that most of the existing AI/machine learning models couldn't incorporate critical 3D protein-ligand information.
  • Solution: They used BIOVIA Generative Therapeutics Design (GTD) with an existing dataset to generate and optimize new lead compounds.
  • Results: By combining AI and 3D pharmacophore modeling, BIOVIA GTD not only re-identified the company's own clinical candidates but also generated 41 closely related compounds and other novel chemical structures within months, proving its ability to shorten timelines and discover new IP. 

What BIOVIA is offering is a mature, cloud-based system for enhancing the power of drug design teams. It enables mixing of explicit chemical, physiochemical properties with 2D ML-models and 3D pharmacophore models to obtain useful suggestions at various stages of the drug discovery process.

Executive Director
Structural Biology and Chemistry - Biopharma Company

Your Questions About BIOVIA, Answered

  • What are the pricing and licensing models for BIOVIA?
    BIOVIA pricing and licensing are tailored to the specific needs and scale of your organization. Because our solutions range from individual applications to enterprise-wide platform deployments, we provide customized quotes to ensure you get the most value. For a detailed quote, please contact our sales experts. We also support the academic community with free versions of tools like BIOVIA Draw and special academic pricing for solutions like the BIOVIA Discovery Studio Visualizer.
     
  • What are the BIOVIA deployment options (Cloud vs. On-Premise)?
    BIOVIA offers flexible deployment models to fit your IT strategy. Our solutions are available as a cloud-native Software-as-a-Service (SaaS) on the BIOVIA Science Cloud and the 3DEXPERIENCE platform, which provides faster implementation, lower IT overhead, automatic updates, and secure global access. For organizations requiring full control over their infrastructure, we also offer traditional on-premise and hybrid deployment options.
     
  • What is the BIOVIA implementation process and how is validation handled?
    BIOVIA ensures a smooth and rapid transition to our digital solutions. For our lab informatics solutions like BIOVIA ONE Lab , we offer a "Quick Start" program that combines our best-in-class ELN with pre-packaged configurations and training to get you operational quickly. For regulated industries, BIOVIA solutions are "validation-ready" by design, supporting GxP compliance with built-in features and providing comprehensive validation kits to accelerate your Computer System Validation (CSV) efforts.
     
  • What is the history of BIOVIA?
    BIOVIA was formerly known as Accelrys, until it was acquired by Dassault Systèmes in April 2014. Following this acquisition, Dassault Systèmes combined the Accelrys portfolio with its own life sciences and BioPLM activities. BIOVIA operates as the scientific-focused brand of Dassault Systèmes, leveraging the collaborative 3DEXPERIENCE platform.

 

​​​Complete the form now to speak to our sales experts and get BIOVIA!

Complete the Form to Contact a BIOVIA Expert!